187 related articles for article (PubMed ID: 1977771)
21. Surface marker expression in acute myeloid leukaemia at first relapse.
Thomas X; Campos L; Archimbaud E; Shi ZH; Treille-Ritouet D; Anglaret B; Fiere D
Br J Haematol; 1992 May; 81(1):40-4. PubMed ID: 1381608
[TBL] [Abstract][Full Text] [Related]
22. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
23. Rapid diagnosis and characterization of acute promyelocytic leukaemia in routine laboratory practice.
Lock RJ; Virgo PF; Kitchen C; Evely RS
Clin Lab Haematol; 2004 Apr; 26(2):101-6. PubMed ID: 15053803
[TBL] [Abstract][Full Text] [Related]
24. [Immunocytochemistry in the diagnosis of acute myeloid leukemia (M0)].
Saito M; Kuriyama K; Nagai K; Nonaka H; Hata T; Tusima H; Tabata S; Arimura K; Souda H; Nakamura H
Rinsho Ketsueki; 1994 Nov; 35(11):1297-304. PubMed ID: 7823396
[TBL] [Abstract][Full Text] [Related]
25. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.
Virgo P; Denning-Kendall PA; Erickson-Miller CL; Singha S; Evely R; Hows JM; Freeman SD
Br J Haematol; 2003 Nov; 123(3):420-30. PubMed ID: 14617000
[TBL] [Abstract][Full Text] [Related]
26. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO).
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
Br J Haematol; 1991 Jul; 78(3):325-9. PubMed ID: 1651754
[TBL] [Abstract][Full Text] [Related]
27. Clinical usefulness of immunocytochemical detection of myeloperoxidase in undifferentiated and biphenotypic acute leukemias.
Musto P; Cascavilla N; Melillo L; Matera R; Carotenuto M
Haematologica; 1991; 76(5):434-6. PubMed ID: 1666891
[TBL] [Abstract][Full Text] [Related]
28. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
[TBL] [Abstract][Full Text] [Related]
29. Intracellular markers in acute myeloid leukemia diagnosis.
Koníková E; Glasová M; Kusenda J; Babusíková O
Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
[TBL] [Abstract][Full Text] [Related]
30. Antibody-directed superantigen-mediated T-cell killing of myeloid leukaemic cell line cells.
Gidlöf C; Carlson B; Dohlsten M; Tötterman TH
Eur J Haematol; 1998 Apr; 60(4):233-9. PubMed ID: 9579876
[TBL] [Abstract][Full Text] [Related]
31. A novel translocation t(2;9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative.
Specchia G; Mestice A; Clelia Storlazzi T; Anelli L; Pannunzio A; Grazia Roberti M; Rocchi M; Liso V
Leuk Res; 2001 Jun; 25(6):501-7. PubMed ID: 11337024
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
Raponi S; De Propris MS; Intoppa S; Milani ML; Vitale A; Elia L; Perbellini O; Pizzolo G; Foá R; Guarini A
Leuk Lymphoma; 2011 Jun; 52(6):1098-107. PubMed ID: 21348573
[TBL] [Abstract][Full Text] [Related]
33. [CD13- and CD33-negative acute myelocytic leukemia (FAB classification; M2) with morphological changes and CD13 expression on recurrence].
Aoyama Y; Yamane T; Kanashima H; Takeoka Y; Koh K; Nakao Y; Yamamura R; Nakamae H; Ohta K; Inoue T; Hino M; Tatsumi N
Rinsho Ketsueki; 2001 Apr; 42(4):314-20. PubMed ID: 11400303
[TBL] [Abstract][Full Text] [Related]
34. CD4+, CD33-, CD13-, CD14- acute monoblastic leukaemia.
Lombard EH; Mansvelt EP
Acta Haematol; 1992; 87(3):151-2. PubMed ID: 1379402
[TBL] [Abstract][Full Text] [Related]
35. Role of C-kit receptor in the diagnosis of leukemia: a relationship between expression of C-kit receptor and that of CD33 in leukemic blasts.
Muroi K; Amemiya Y; Miura Y; Nakamura M; Suda T
Leuk Res; 1993 Aug; 17(8):725-6. PubMed ID: 7689130
[No Abstract] [Full Text] [Related]
36. Immunophenotyping of acute lymphoblastic leukaemia in routinely processed bone marrow biopsy specimens.
Toth B; Wehrmann M; Kaiserling E; Horny HP
J Clin Pathol; 1999 Sep; 52(9):688-92. PubMed ID: 10655992
[TBL] [Abstract][Full Text] [Related]
37. [Monoclonal antibody therapy targeting surface antigens of leukemic cells].
Meng FY; Fu YB
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):441-3. PubMed ID: 15854546
[No Abstract] [Full Text] [Related]
38. [The use of monoclonal antibodies for immunologic typing and prognosis prediction in acute non-lymphoblastic leukemia].
Chen GB; Tang MH; Yang TY
Zhonghua Nei Ke Za Zhi; 1993 Jun; 32(6):405-8. PubMed ID: 7903627
[TBL] [Abstract][Full Text] [Related]
39. Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells.
Chen P; Wang J; Hope K; Jin L; Dick J; Cameron R; Brandwein J; Minden M; Reilly RM
J Nucl Med; 2006 May; 47(5):827-36. PubMed ID: 16644753
[TBL] [Abstract][Full Text] [Related]
40. Successful use of gemtuzumab ozogamicin in a child with relapsed CD33-positive acute lymphoblastic leukaemia.
Cotter M; Rooney S; O'Marcaigh A; Smith OP
Br J Haematol; 2003 Aug; 122(4):687-8. PubMed ID: 12899727
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
